跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,693 条关于
“Lu 177 vipivotide tetraxetan”
全部
2,693
临床试验
1,333
药物
914
机构
14
资讯
432
去年
Lutetium Lu 177 Vipivotide Tetraxetan Shows Promise in Prostate Cancer Treatment
3年前
FDA Approves Lutetium Lu 177 Vipivotide Tetraxetan for PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
去年
Advances in Metastatic Prostate Cancer Treatment: Avenues for Extending Survival
去年
CellBion's Lu-177-DGUL Shows Promise in Metastatic Prostate Cancer Treatment
去年
177Lu-PSMA-I&T Demonstrates rPFS Benefit in mCRPC Patients in ECLIPSE Trial
2年前
Novel AR Degraders and Emerging Therapies Show Promise in Advanced Prostate Cancer Treatment
7个月前
PYLARIFY Becomes First Blockbuster Radiodiagnostic with $1.06 Billion in 2024 Sales
去年
Canadian Negotiations Stall for Novartis' Pluvicto, Leaving Prostate Cancer Patients in Limbo
7个月前
Former Novartis CMO John Tsai Appointed Global Head of R&D at Daiichi Sankyo
去年
FDA Expands Pluvicto Approval for Earlier Treatment of Metastatic Prostate Cancer
第 1 页，共 44 页
上一页
下一页
